I’m 31 now and I found out I had major depressive disorder when I was 19. I had a miserable freshman year of college, but I didn't really know what was wrong. I saw a therapist and the following ...
Citation: Using machine learning to predict how people diagnosed with major depressive disorder respond to treatment (2025, January 22) retrieved 11 February 2025 from https://medicalxpress.com ...
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...
The Sandbox Collective’s “Next to Normal” is a cathartic presentation of what it’s like to be human: to feel, to grieve, to ...
Over the last 20 years, we’ve seen major strides in the treatment options for major depressive disorder. We now understand that depression isn’t the same for everyone. The idea is to identify ...
Image credit: Koldunov/Getty Images. Major depressive disorder (MDD) is the most commonly diagnosed mental disorder globally. The amount of people with MDD continues to increase every year.
Hundreds of millions of people around the world live with major depressive disorder (MDD), making it the most commonly diagnosed mental disorder with numbers increasing annually. Past studies show ...
Half of the study group met criteria for AUD in the past year and were evenly divided in terms of those who had or had not experienced a major depressive disorder in the past year. Individuals who had ...
Hosted on MSN23d
Using machine learning to predict how people diagnosed with major depressive disorder respond to treatmentMajor depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of interest in everyday activities, appetite changes, sleep disturbances and ...
The Atlantic on MSN14d
In Search of the Book That Would Save Her LifeChihaya’s version of bibliophobia grew out of the fear of one book in particular—the monograph that her career demanded and ...
Johnson & Johnson's Spravato has been approved to treat a major depressive disorder in adults who have had an inadequate response to at least two oral antidepressants, the FDA announced Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback